Skip to main content

Table 1 Patient characteristics displayed by cohort time and total (N = 12,558)

From: Diagnostic intervals before and after implementation of cancer patient pathways – a GP survey and registry based comparison of three cohorts of cancer patients

 

Before

During

After

Total

   

After-total

After-CPP

After-no CPP

 
 

n (%)

n (%)

n (%)

n (%)

n (%)

n (%)

All

2,041 (100)

6,660 (100)

3,857 (100)

1,432 (100)

2,425 (100)

12,558 (100)

Gender

      

Male

981 (48.1)

3,305 (49.6)

2,051 (53.2)

729 (50.9)

1,322 (54.5)

6,337 (50.5)

Female

1,060 (51.9)

3,355 (50.4)

1,806 (46.8)

703 (49.1)

1,103 (45.5)

6,221 (49.5)

Age groups (years):

     

18-44

176 (8.6)

490 (7.4)

300 (7.8)

106 (7.4)

194 (8.0)

966 (7.7)

45-54

232 (11.4)

771 (11.6)

464 (12.0)

171 (11.9)

293 (12.1)

1,467 (11.7)

55-64

479 (23.5)

1,640 (24.6)

862 (22.3)

336 (23.5)

526 (21.7)

2,981 (23.7)

65-74

562 (27.5)

1,924 (28.9)

1,162 (30.1)

432 (30.2)

730 (30.1)

3,648 (29.0)

75-

592 (29.0)

1,835 (27.6)

1,069 (27.7)

387 (27.0)

682 (28.1)

3,496 (27.8)

Diagnoses

      

Colorectal

282 (13.8)

1,020 (15.3)

619 (16.0)

222 (15.5)

397 (16.4)

1,921 (15.3)

Lung

278 (13.6)

930 (14.0)

477 (12.4)

195 (13.6)

282 (11.6)

1,685 (13.4)

Melanoma, malignant

125 (6.1)

371 (5.6)

228 (5.9)

82 (5.7)

146 (6.0)

724 (5.8)

Breast

305 (14.9)

1,084 (16.3)

524 (13.6)

325 (22.7)

199 (8.2)

1,913 (15.2)

Prostate

213 (10.4)

858 (12.9)

560 (14.5)

220 (15.4)

340 (14.0)

1,631 (13.0)

Other

838 (41.1)

2,397 (36.0)

1,449 (37.6)

388 (27.1)

1,061 (43.8)

4,684 (37.3)

Co-morbidity

     

None

1,519 (74.4)

5,008 (75.2)

2,912 (75.5)

1,101 (76.9)

1,801 (74.6)

9,439 (75.2)

Medium

432 (21.2)

1,429 (21.5)

786 (20.4)

278 (19.4)

508 (21.0)

2,647 (21.1)

High

90 (4.4)

223 (3.3)

159 (4.1)

53 (3.7)

106 (4.4)

472 (3.8)

Educational level – ISCED

     

Low

754 (36.9)

2,820 (42.3)

1,430 (37.1)

547 (38.2)

883 (36.4)

5,004 (39.8)

Medium

709 (34.7)

2,345 (35.2)

1,506 (39.0)

537 (37.5)

969 (40.0)

4,560 (36.3)

High

386 (18.9)

1,161 (17.4)

770 (20.0)

293 (20.5)

477 (19.7)

2,317 (18.5)

Missing

192 (9.4)

334 (5.0)

151 (3.9)

55 (3.8)

96 (4.0)

677 (5.4)

Disposable Income – OECD (EURO)

     

Low

639 (31.3)

2,113 (31.7)

1269 (32.9)

474 (33.1)

795 (32.8)

4,021 (32.0)

Medium

648 (31.7)

2,169 (32.6)

1313 (34.0)

466 (32.5)

847 (34.9)

4,130 (32.9)

High

662 (32.4)

2,185 (32.8)

1271 (33.0)

491 (34.3)

780 (32.2)

4,118 (32.8)

Missing

92 (4.5)

193 (2.9)

4 (0.1)

1 (0.1)

3 (0.1)

289 (2.3)

  1. Column five and six display the ‘after cohort’ divided by referral route (referred to a Cancer Patient Pathway (after-CPP) or not (after-no CPP)).